Geron
GERN
#6333
Rank
C$1.12 B
Marketcap
C$1.76
Share price
-3.05%
Change (1 day)
-68.77%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -C$64.95 Million

According to Geron's latest financial reports the company's current earnings are C$0.18 Billion. In 2024 the company made an earning of -C$0.22 Billion, an increase over its 2023 earnings that were of -C$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$64.95 Million-69.94%
2024 -C$0.22 Billion-11.23%
2023 -C$0.25 Billion30.22%
2022 -C$0.19 Billion20.15%
2021 -C$0.16 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$99.24 Million130.68%
2018 -C$43.02 Million8.84%
2017 -C$39.53 Million-3.08%
2016 -C$40.78 Million-22080.6%
2015 C$0.18 M-100.38%
2014 -C$49.28 Million-7.14%
2013 -C$53.06 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$97.24 Million-2.51%
2008 -C$99.75 Million14.65%
2007 -C$87 Million32.68%
2006 -C$65.57 Million25.59%
2005 -C$52.21 Million4.36%
2004 -C$50.03 Million19.73%
2003 -C$41.79 Million-15.46%
2002 -C$49.43 Million1.94%
2001 -C$48.49 Million33.59%
2000 -C$36.3 Million27.53%
1999 -C$28.46 Million63.13%
1998 -C$17.45 Million15.6%
1997 -C$15.1 Million-10.66%
1996 -C$16.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-C$13.14 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.68 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.15 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.19 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$95.86 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA